BMO Capital analyst Gary Nachman raised the price target on Abbvie (NYSE: ABBV) to $129.00 (from $127.00) while maintaining an ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View Analyst PT Change

RBC Capital Reiterates Outperform on Abbvie (ABBV) Ahead of Numerous CatalystsMay 3, 2021 7:14 AM Abbvie (ABBV) PT Raised to $118 at Truist SecuritiesMay 3, 2021 7:07 AM Abbvie (ABBV) PT Raised to $128 at Mizuho SecuritiesMay 3, 2021 6:38 AM Abbvie (ABBV) PT Raised to $127 at Wolfe ResearchMay 3, 2021 5:47 AM Form 8-K AbbVie Inc. For: Apr 30April 30, 2021 7:45 AM AbbVie (ABBV) Tops Q1 EPS by 12c, Offers FY GuidanceApril 30, 2021 7:43 AM AbbVie Reports First-Quarter 2021 Financial ResultsApril 30, 2021 7:42 AM